Skip to main content
. 2014 Apr 28;3:15. doi: 10.1186/2049-9957-3-15

Table 2.

Number of institutions involved in drug, diagnostics, vaccines, and traditional medicine development in the ASEAN

DRUG DEVELOPMENT
Country No. involved in Drug Development No. involved in Target Discovery No. involved in Screening No. involved in Product Development No. involved in Clinical Trials No. involved in Manufacturing No. involved in M&E
Bruneia
 -
 -
 -
 -
 -
 -
 -
Cambodiac
 20
 10
 -
 2
 -
 10
 10
Indonesiab
 40
 22
 23
 14
 18
 9
 16
Laosb
 3
 -
 -
 -
 -
 -
 -
Malaysiab
 33
 10
 6
 7
 3
 1
 3
Myanmarc
 19
 14
 3
 -
 2
 -
 2
Philippinesb
 19
 6
 6
 3
 9
 2
 7
Singapored
 6
 6
 -
 4
 1
 -
 1
Thailandc
 90
 59
 -
 12
 27
 -
 33
Vietnamb
 18
 4
 -
 6
 6
 12
 -
DIAGNOSTICS DEVELOPMENT
Country
 No. involved in Diagnostics Development
 No. involved in Target Discovery
 Platform Development
 No. involved in Product Development
 No. involved in Clinical Trials
 No. involved in Manufacturing
 No. involved in M&E
Bruneia
 -
 -
 -
 -
 -
 -
 -
Cambodiac
 4
 -
 -
 1
 2
  
 2
Indonesiab
 21
 16
 1
 4
 -
 2
 18
Laosb
 -
 -
 -
 -
 -
 -
 -
Malaysiab
 50
 15
 12
 11
 6
 -
 6
Myanmarc
 2
 -
 -
 -
 1
 -
 1
Philippinesb
 13
 11
  
 8
 6
 2
 1
Singaporee
 5/546
 5
 4
 -
 -
 -
 5
Thailandc
 31
 6
 8
 3
 -
 -
 15
Vietnamb
 7
 4
 5
 4
 1
 2
 -
VACCINES DEVELOPMENT
Country
 No. involved in Vaccine Development
 No. involved in Target Discovery
 No. involved in Screening
 No. involved in Vaccine Development
 No. involved in Clinical Trials
 No. involved in Manufacturing
 No. involved in M&E
Bruneia
 -
 -
 -
 -
 -
 -
 -
Cambodiab
 14
 8
 1
 -
 -
 -
 1
Indonesia
 14
 2
 -
 7
 2
 2
 1
Laosa
 -
 -
 -
 -
 -
 -
 -
Malaysiab
 9
 4
 -
 2
 2
 -
 1
Myanmarb
 9
 1
 8
 -
 -
 -
 -
Philippinesb
 12
 6
 1
 1
 5
 1
 1
Singaporef
 4/110
 4
 4
 -
 -
 -
 -
Thailandb
 21
 12
 4
 2
 -
 -
 5
Vietnamg
 6
 -
 -
 -
 -
 5
 -
TRADITIONAL MEDICINE DEVELOPMENT
Country
 No. involved in Traditional Medicine Development
 No. involved in Target Discovery
 No. involved in Screening
 No. involved in Product Development
 No. involved in Clinical Trials
 No. involved in Manufacturing
 No. involved in M&E
Bruneia
 -
 -
 -
 -
 -
 -
 -
Cambodiac
 2
 -
 -
 -
 -
 -
 -
Indonesiab
 16
 7
  
  
 2
 1
 2
Laosb
 -
 -
 -
 -
 -
  
 -
Malaysiab
 188
 8
 5
 6
 2
 -
 2
Myanmarc
 -
 -
 -
 -
 -
 -
 -
Philippinesc
 16
 12
 14
 8
 4
 3
 1
Singaporeh
 -
 -
 -
 -
 -
 -
 -
Thailandc
 4
 2
 -
 2
 -
 -
 -
Vietnamb 12 5 6 5 3 7 -

Sources: Scopus (Elsevier, 2010) and country reports.

aNo specific information available.

bData based on the country report.

cData from internet sources.

dAlthough based on the country report, this does not summarize the R&D in Singapore.

eThe country report states five institutions while internet sources indicate as many as 546 institutions.

fThe country report states four institutions while the internet source cites 110 institutions.

gThe involvement of institutions in the specific stage of development is not available in the supplied information.

hNo data available for Singapore.